FMR LLC 13D and 13G filings for CYTEIR THERAPEUTICS INC:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-07-10 10:20 am Sale | 2023-07-07 | 13G | CYTEIR THERAPEUTICS INC CYTT | FMR LLC | 827,867 2.331% | -2,080,509 (-71.54%) | Filing |
| 2023-02-09 09:59 am Sale | 2023-02-09 | 13G | CYTEIR THERAPEUTICS INC CYTT | FMR LLC | 2,908,376 8.206% | -1,140,617 (-28.17%) | Filing |
| 2022-02-09 09:11 am Sale | 2022-02-08 | 13G | CYTEIR THERAPEUTICS INC CYTT | FMR LLC | 4,048,993 11.447% | -236,666 (-5.52%) | Filing |
| 2021-10-12 09:25 am Purchase | 2021-10-08 | 13G | CYTEIR THERAPEUTICS INC CYTT | FMR LLC | 4,285,659 12.116% | 4,285,659 (New Position) | Filing |